Romy Gaillard1, Paul H C Eilers, Siham Yassine, Albert Hofman, Eric A P Steegers, Vincent W V Jaddoe. 1. The Generation R Study Group, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Epidemiology, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands; Department of Paediatrics, Erasmus Medical Center - Sophia Children's Hospital, Rotterdam, the Netherlands.
Abstract
BACKGROUND: To determine sociodemographic and life style-related risk factors and trimester specific maternal, placental, and fetal consequences of maternal anaemia and elevated haemoglobin levels in pregnancy. METHODS: In a population-based prospective cohort study of 7317 mothers, we measured haemoglobin levels in early pregnancy [gestational age median 14.4 weeks (inter-quartile-range 12.5-17.5)]. Anaemia (haemoglobin ≤11 g/dl) and elevated haemoglobin levels (haemoglobin ≥13.2 g/dl) were defined according to the WHO criteria. Maternal blood pressure, placental function and fetal growth were measured in each trimester. Data on gestational hypertensive disorders and birth outcomes was collected from hospitals. RESULTS: Older maternal age, higher body mass index, primiparity and European descent were associated with higher haemoglobin levels (P < 0.05). Elevated haemoglobin levels were associated with increased systolic and diastolic blood pressure throughout pregnancy (mean differences 5.1 mmHg, 95% confidence interval [CI] 3.8, 6.5 and 4.1 mmHg, 95% CI 3.0, 5.2, respectively) and with a higher risk of third trimester uterine artery notching (RR 1.3, 95% CI 1.0, 1.7). As compared with maternal normal haemoglobin levels, not anaemia, but elevated haemoglobin levels were associated with fetal head circumference, length, and weight growth restriction from third trimester onwards (P < 0.05). Elevated haemoglobin levels were associated with increased risks of gestational hypertensive disorders (RR 1.4, 95% CI 1.1, 1.8) and adverse birth outcomes (RR 1.4, 95% CI 1.1, 1.7). CONCLUSIONS: In a low-risk population, various sociodemographic and life style factors affect haemoglobin levels during pregnancy. Elevated haemoglobin levels are associated with increased risks of maternal, placental, and fetal complications.
BACKGROUND: To determine sociodemographic and life style-related risk factors and trimester specific maternal, placental, and fetal consequences of maternal anaemia and elevated haemoglobin levels in pregnancy. METHODS: In a population-based prospective cohort study of 7317 mothers, we measured haemoglobin levels in early pregnancy [gestational age median 14.4 weeks (inter-quartile-range 12.5-17.5)]. Anaemia (haemoglobin ≤11 g/dl) and elevated haemoglobin levels (haemoglobin ≥13.2 g/dl) were defined according to the WHO criteria. Maternal blood pressure, placental function and fetal growth were measured in each trimester. Data on gestational hypertensive disorders and birth outcomes was collected from hospitals. RESULTS: Older maternal age, higher body mass index, primiparity and European descent were associated with higher haemoglobin levels (P < 0.05). Elevated haemoglobin levels were associated with increased systolic and diastolic blood pressure throughout pregnancy (mean differences 5.1 mmHg, 95% confidence interval [CI] 3.8, 6.5 and 4.1 mmHg, 95% CI 3.0, 5.2, respectively) and with a higher risk of third trimester uterine artery notching (RR 1.3, 95% CI 1.0, 1.7). As compared with maternal normal haemoglobin levels, not anaemia, but elevated haemoglobin levels were associated with fetal head circumference, length, and weight growth restriction from third trimester onwards (P < 0.05). Elevated haemoglobin levels were associated with increased risks of gestational hypertensive disorders (RR 1.4, 95% CI 1.1, 1.8) and adverse birth outcomes (RR 1.4, 95% CI 1.1, 1.7). CONCLUSIONS: In a low-risk population, various sociodemographic and life style factors affect haemoglobin levels during pregnancy. Elevated haemoglobin levels are associated with increased risks of maternal, placental, and fetal complications.
Authors: Elise M Philips; Leonardo Trasande; Linda G Kahn; Romy Gaillard; Eric A P Steegers; Vincent W V Jaddoe Journal: Hum Reprod Date: 2019-02-01 Impact factor: 6.918
Authors: Claudia J Kruithof; Marjolein N Kooijman; Cornelia M van Duijn; Oscar H Franco; Johan C de Jongste; Caroline C W Klaver; Johan P Mackenbach; Henriëtte A Moll; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Eppo B Wolvius; Albert Hofman; Vincent W V Jaddoe Journal: Eur J Epidemiol Date: 2014-12-21 Impact factor: 8.082
Authors: Hugo G Quezada-Pinedo; Sara M Mensink-Bout; Irwin K Reiss; Vincent W V Jaddoe; Marijn J Vermeulen; Liesbeth Duijts Journal: Pediatr Pulmonol Date: 2021-03-03
Authors: Ana C M G Figueiredo; Isaac S Gomes-Filho; Roberta B Silva; Priscilla P S Pereira; Fabiana A F Da Mata; Amanda O Lyrio; Elivan S Souza; Simone S Cruz; Mauricio G Pereira Journal: Nutrients Date: 2018-05-12 Impact factor: 5.717
Authors: Anna K Knight; Anne L Dunlop; Varun Kilaru; Dawayland Cobb; Elizabeth J Corwin; Karen N Conneely; Alicia K Smith Journal: PLoS One Date: 2018-10-10 Impact factor: 3.240